Nyrada Inc (ASX:NYR) Receives A$1.2M R&D Tax Incentive Rebate Nov 19, 2022 | ASX News, Nyrada Inc (ASX:NYR)
Incannex Completes Dosing Patients in Phase 2 Proof-of-Concept Trial of IHL-42X for the Treatment of Obstructive Sleep Apnoea Dec 20, 2021 | ASX News, Incannex Healthcare (ASX:IHL)
